Showing results (2911-2920 of 8,704) with videos related to
Sort By:
Pageof 871
Malaria Journal|November 4, 2008
Willingness and ability to pay for artemisinin-based combination therapy in rural TanzaniaEleonor C Saulo, Birger C Forsberg, Zul Premji, et al.Malaria Journal|October 28, 2008
Trends in malaria morbidity following the introduction of artesunate plus amodiaquine combination in M'lomp village dispensary, south-western SenegalSophie Sarrassat, Paul Senghor, Jean Yves Le HesranMalaria Journal|September 21, 2007
Interdependence of domestic malaria prevention measures and mosquito-human interactions in urban Dar es Salaam, TanzaniaYvonne Geissbühler, Prosper Chaki, Basiliana Emidi, et al.Malaria Journal|September 22, 2007
Malaria-related mortality based on verbal autopsy in an area of low endemicity in a predominantly rural population in EthiopiaWakgari Deressa, Mesganaw Fantahun, Ahmed AliMalaria Journal|April 5, 2007
Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western UgandaRichard Ndyomugyenyi, Pascal Magnussen, Siân ClarkeMalaria Journal|March 31, 2007
Synergy between repellents and non-pyrethroid insecticides strongly extends the efficacy of treated nets against Anopheles gambiaeCédric Pennetier, Vincent Corbel, Pélagie Boko, et al.Malaria Journal|April 13, 2007
Rapid detection of Pfcrt and Pfmdr1 mutations in Plasmodium falciparum isolates by FRET and in vivo response to chloroquine among children from Osogbo, NigeriaOlusola Ojurongbe, Titus O Ogungbamigbe, Adetayo F Fagbenro-Beyioku, et al.Malaria Journal|October 31, 2008
A highly sensitive, PCR-based method for the detection of Plasmodium falciparum clones in microtiter platesSteven P Maher, Bharath Balu, Doug A Shoue, et al.Malaria Journal|September 8, 2007
World Antimalarial Resistance Network (WARN) II: in vitro antimalarial drug susceptibilityDavid J Bacon, Ronan Jambou, Thierry Fandeur, et al.Malaria Journal|September 8, 2007
World Antimalarial Resistance Network (WARN) IV: clinical pharmacologyKaren I Barnes, Niklas Lindegardh, Olumide Ogundahunsi, et al.Pageof 871